Skip to content

Supersaturation and Precipitation of Diclofenac in the Stomach of Healthy Volunteers

Supersaturation and Precipitation of Diclofenac in the Stomach of Healthy Volunteers

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02007161
Acronym
DDD13DICLO
Enrollment
10
Registered
2013-12-10
Start date
2013-12-31
Completion date
2014-12-31
Last updated
2013-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Supersaturation and Precipitation in the Stomach

Brief summary

Investigate the supersaturation and precipitation behaviour of diclofenac in the stomach of healthy volunteers.

Interventions

DRUGDiclofenac potassium 50 mg

Diclofenac potassium 50 mg

Sponsors

KU Leuven
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy volunteers * Age 20 - 35 years

Exclusion criteria

* Illness * Acute / Chronic gastric disorder * Use of medicine * (possible) pregnancy * Frequent exposure to X-rays during the past year * HIV / Hepatitis B Virus or Hepatitis C Virus infection

Design outcomes

Primary

MeasureTime frame
Area under the Concentration - Time CurveEvery 10 minutes for 2 h

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026